Immunoproteasome subunits LMP2 and LMP7 downregulation in primary malignant melanoma lesions
Authors:
- Petra GoettePGPetra Goette
- Janet MoersJMJanet Moers
- Anette LindekeALAnette Lindeke
- Manfred GoosMGManfred Goos
- Soldano FerroneSFSoldano Ferrone
- Stephan N WagnerSWStephan N Wagner
- 1 August 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Melanoma Research
- Vol. 13 (4) , 371-377
Abstract
Recently, expression of the immunoproteasome subunits low molecular protein (LMP) 2 or LMP7 was shown to reduce the presentation of certain major histocompatibility complex (MHC) class I-restricted tumour peptide epitopes in renal cell carcinoma and melanoma cells. This may provide the tumour cells with an immune escape mechanism. To test the relevance of this hypothesis, we have taken advantage of the fact that spontaneous regression of human primary melanoma is thought to be the result of a successful peptide-specific cellular immune response in vivo. Immunohistochemical staining with anti-LMP2 and anti-LMP7 xenoantibodies showed a significantly higher expression of these immunoproteasome subunits in primary melanoma lesions exhibiting histological signs of tumour regression than in primary melanoma lesions without regression phenomena. In spontaneously regressing melanoma lesions, LMP2 and LMP7 expression was significantly associated with the presence of tumour-infiltrating lymphocytes. Our results are compatible with the possibility that the expression of the immunoproteasome subunits LMP2 and LMP7 rather than their downregulation in melanoma cells is associated with the presence of a successful anti-melanoma immune response.Keywords
This publication has 24 references indexed in Scilit:
- Interferon-γ inducible exchanges of 20S proteasome active site subunits: Why?Biochimie, 2001
- DEGRADATION OF CELL PROTEINS AND THE GENERATION OF MHC CLASS I-PRESENTED PEPTIDESAnnual Review of Immunology, 1999
- Hierarchies of antigen‐specific cytotoxic T‐cell responsesImmunological Reviews, 1998
- The proteasome: a protein‐destroying machineGenes to Cells, 1998
- MECHANISMS OF MHC CLASS I–RESTRICTED ANTIGEN PROCESSINGAnnual Review of Immunology, 1998
- Two distinct proteolytic processes in the generation of a major histocompatibility complex class I-presented peptideProceedings of the National Academy of Sciences, 1997
- The proteasome‐specific inhibitor lactacystin blocks presentation of cytotoxic T lymphocyte epitopes in human and murine cellsEuropean Journal of Immunology, 1997
- Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I moleculesCell, 1994
- γ-Interferon and expression of MHC genes regulate peptide hydrolysis by proteasomesNature, 1993
- MHC-linked LMP gene products specifically alter peptidase activities of the proteasomeNature, 1993